News

EssilorLuxottica: Share Capital and Voting Rights Update

EssilorLuxottica: Share Capital and Voting Rights Update

Disclosure of Share Capital and Voting Rights Outstanding

As of July 31, 2024, the outstanding shares and voting rights of EssilorLuxottica, a leading global company in the design, manufacture, and distribution of ophthalmic lenses, frames, and sunglasses, are detailed below.

Outstanding Shares and Voting Rights

Understanding the current status of shares and voting rights is essential for grasping the company's governance framework. On the specified date, the total number of shares outstanding is 457,320,927. This figure reflects the company’s broad shareholder base and the significant influence each shareholder can have on corporate decisions.

Real Voting Rights

After excluding treasury shares, the actual number of real voting rights is 455,577,543. This number illustrates the genuine voting power that shareholders possess, highlighting their ability to engage in key corporate governance matters.

Theoretical Voting Rights

When treasury shares are included, the theoretical number of voting rights aligns with the total shares outstanding, which is 457,320,927. This figure represents the maximum voting potential within the company’s current equity structure.

Voting Rights Cap

It's important to understand that voting rights are limited to a maximum of 31%. This cap ensures that no single shareholder can dominate the voting process, fostering a balanced governance environment at EssilorLuxottica. The specifics of this cap are outlined in article 23 of the company’s by-laws, ensuring equitable participation for all shareholders in decision-making.

Further Information

For those seeking more detailed insights, it is advisable to review the Prospectus, which received Visa No. 18-460 from the AMF on September 28, 2018, along with its Securities Note Supplement bearing Visa No. 18-494 from the AMF on October 23, 2018. These documents can be accessed on the official EssilorLuxottica website, offering transparency and vital information for shareholders.

Conclusion

EssilorLuxottica continues to be a key player in the ophthalmic sector. The share capital and voting rights information provided as of July 31, 2024, underscores its dedication to governance and engaging with stakeholders. Investors and interested parties are encouraged to remain updated on future developments as the company progresses in the market.

Frequently Asked Questions

What is EssilorLuxottica's total shares outstanding as of July 31, 2024?

As of July 31, 2024, EssilorLuxottica has a total of 457,320,927 shares outstanding.

What are real voting rights?

Real voting rights refer to the number of votes shareholders can cast, excluding any treasury shares, totaling 455,577,543 for EssilorLuxottica.

What is the theoretical number of voting rights?

The theoretical number of voting rights, which includes treasury shares, is equal to the total shares outstanding, amounting to 457,320,927.

What is the voting rights cap for EssilorLuxottica shareholders?

The voting rights for shareholders are capped at 31%, preventing any single shareholder from exerting excessive influence.

Where can I find further information about EssilorLuxottica?

Further information can be found in the Prospectus and Securities Note Supplement available on EssilorLuxottica's official website.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Govee Stirs Halloween Chills with New Sarah Gellar Ad

Updated Category News Views 4

Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...

Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook

Updated Category News Views 3

Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...

Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts

Updated Category News Views 2

The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...

Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands

Updated Category News Views 3

Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...

Continue Reading
The Real Cost of Cabinet Decisions: Refinish or Replace?

Updated Category News Views 3

Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...

Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk

Updated Category News Views 8

Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...

Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin

Updated Category News Views 3

Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...

Continue Reading
Trading Platforms Poised for Billions by 2031

Updated Category News Views 4

Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....

Continue Reading
Kal Plastics Showcases at Design-2-Part Expo

Updated Category News Views 3

Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...

Continue Reading

Top 5 Most Recently Viewed Articles

Key Insights from Akero Therapeutics' Recent Financials and Updates

Updated Category News Views 90

Akero Therapeutics Unveils Financial Results and Business Progress In a significant move, Akero Therapeutics, Inc. (NASDAQ: AKRO) disclosed notable advancements in its financial performance and ongoing clinical studies. The company, a pioneer in developing innovative treatments for metabolic diseases, has presented its fourth quarter and total financial results for the...

Continue Reading
SF Intra-city's Exceptional Performance Fuels Dynamic Growth

Updated Category News Views 171

SF Intra-city's Remarkable Growth in 1H 2025 In the competitive landscape of on-demand delivery, SF Intra-city has showcased its resilience and adaptability, reporting impressive results for the period ending June 30, 2025. The Company announced a staggering 48.8% year-on-year increase in revenue, surpassing RMB 10 billion. This remarkable financial performance is...

Continue Reading
Logility Set to Release Q3 Financial Results for FY 2025

Updated Category News Views 190

Logility to Announce Third Quarter Financial Results Logility Supply Chain Solutions, Inc. (NASDAQ: LGTY), a leader in AI-driven supply chain planning software, is preparing to release its financial results for the third quarter of the fiscal year 2025. This important announcement is scheduled to take place after the U.S. financial markets close on an upcoming Thursday....

Continue Reading
Understanding Datadog's Stock and Options Dynamics

Updated Category News Views 217

Exploring Datadog's Stock Performance and Options Insights Recent bullish interest is brewing among financial giants for Datadog, a prominent player in the cloud monitoring space. Our comprehensive analysis of options trading activity for Datadog (DDOG) unveils a series of captivating trends and trading strategies. Started with evaluating the options history for Datadog,...

Continue Reading
Personalis Reports Impressive Revenue Growth for 2024

Updated Category News Views 468

Personalis Releases Preliminary Revenue for 2024 Personalis, Inc. (Nasdaq: PSNL), a frontrunner in advanced genomics focusing on precision oncology, has unveiled its preliminary revenue figures for the fourth quarter and the entirety of 2024. This announcement signals significant growth in the company's offerings and highlights its ongoing commitment to enhancing cancer...

Continue Reading